Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 4,609-4,620 of 10,592
Drug study icon
WithdrawnNCT04311294

Development of a Selective ALDH2 Inhibitor to Treat AUD

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugA study involving a medication or substance.Over 21 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Addiction
Behavioral study icon
Active Not RecruitingNCT04281134

Development of Adaptive Deep Brain Stimulation for OCD

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can play a useful role in care. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can better support energy, concentration, and everyday functioning.

In United States
OCDBehavioralFrom 21 Years to 70 Years
Countries
United States
Sponsor
Baylor College of Medicine
Condition
OCD
Behavioral study icon
Active Not RecruitingNCT03457675

Development of Adaptive Deep Brain Stimulation for OCD (Phase 1a)

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can play a useful role in care. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

In United States
OCDBehavioralFrom 21 Years to 70 Years
Countries
United States
Sponsor
Baylor College of Medicine
Condition
OCD
Drug study icon
CompletedNCT02025998

Development of Ibudilast for Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugFrom 21 Years to 65 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Addiction
Drug study icon
CompletedNCT02046200

Development of Ivermectin for Alcohol Use Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugFrom 21 Years to 65 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Addiction
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.